Courage Over Cancer
![NIH Grant](/sites/default/files/styles/future_focus_487x330/public/2023-07/NIH-Grant-1.png?h=598ef53e&itok=IfCdRFAE)
NIH grant to boost ovarian cancer drug development
The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.
Read more![Enrique Diaz](/sites/default/files/styles/future_focus_487x330/public/2023-07/E0_213_13070105_3967745011_5.jpg?h=810b210d&itok=OWbuxL5q)
Boosting Hispanic representation in cancer research
The Mays Cancer Center has been named a founding partner of the Advancing Inclusive Research Site Alliance, a coalition of clinical research sites seeking to advance the representation of diverse patient populations in clinical trials.
Read more